dicloxacillin

Absorption: Rapidly but incompletely (35–76%) absorbed from the GI tract.

Distribution: Widely distributed; penetration into CSF is minimal but sufficient in the presence of inflamed meninges; cross the placenta and enter breast milk.

Protein Binding: 96–98%.

Metabolism/Excretion: Some metabolism by the liver (6–10%) and some renal excretion of unchanged drug (60%); small amounts eliminated in the feces via the bile.

Half-Life: 0.5–1 hr (↑ in severe hepatic and renal dysfunction).

Time/Action Profile ⬆ ⬇

ROUTE	ONSET	PEAK	DURATION
Dicloxacillin PO	30 min	30–120 min	6 hr

Contraind./Precautions ⬆ ⬇

Contraindicated in:

Previous hypersensitivity to penicillins (cross-sensitivity exists with cephalosporins and other beta-lactam antibiotics).

Use Cautiously in:

Severe renal or hepatic impairment.

Adv. Reactions/Side Effects ⬆ ⬇

Derm: rash, urticaria

GI: diarrhea, epigastric distress, nausea, vomiting, ↑liver enzymes, CLOSTRIDIOIDES DIFFICILE-ASSOCIATED DIARRHEA (CDAD)

GU: interstitial nephritis

Hemat: eosinophilia, leukopenia

Neuro: SEIZURES

Misc: ANAPHYLAXIS AND SERUM SICKNESSALLERGIC REACTIONS INCLUDING , superinfection

Interactions ⬆ ⬇

Drug-drug:

May ↓ effectiveness of oral contraceptive agents.
Probenecid↓ renal excretion and ↑ blood levels (therapy may be combined for this purpose).
Neomycin may ↓ absorption.
Concurrent use with methotrexate↓ methotrexate elimination and ↑ risk of serious toxicity.

Route/Dosage ⬆ ⬇

PO (Adults and Children ≥40 kg): 125–250 mg q 6 hr (up to 2 g/day).
PO (Children <40 kg): 25–50 mg/kg/day divided q 6 hr; (up to 50–100 mg/kg/day divided q 6 hr has been used for osteomyelitis), maximum: 2 g/day.

Availability ⬆ ⬇

(Generic available)

Capsules: 250 mg; 500 mg

Assessment ⬆ ⬇

Assess for infection (vital signs; appearance of wound, sputum, urine, and stool; WBC) at beginning of and throughout therapy.
Obtain a history before initiating therapy to determine previous use of and reactions to cephalosporins or other beta-lactam antibiotics. Persons with a negative history of penicillin sensitivity may still have an allergic response.
Obtain specimens for culture and sensitivity prior to initiating therapy. First dose may be given before receiving results.
Observe for signs and symptoms of anaphylaxis (rash, pruritus, laryngeal edema, wheezing, abdominal pain). Discontinue the drug and notify health care professional immediately if these occur. Keep epinephrine, an antihistamine, and resuscitation equipment close by in the event of an anaphylactic reaction.
Monitor bowel function. Diarrhea, abdominal cramping, fever, and bloody stools should be reported to health care professional promptly as a sign of Clostridioides difficile-associated diarrhea (CDAD). May begin up to several wk following cessation of therapy.

Lab Test Considerations:

May cause leukopenia and neutropenia, especially with prolonged therapy or hepatic impairment.
- May cause positive direct Coombs’ test result.
- May cause ↑ in AST, ALT, LDH, and serum alkaline phosphatase concentrations.

Implementation ⬆ ⬇

PO: Administer around the clock on an empty stomach at least 1 hr before or 2 hr after meals. Take with a full glass of water; acidic juices may decrease absorption of penicillins.

Patient/Family Teaching ⬆ ⬇

Instruct patient to take medication around the clock and to finish the drug completely as directed, even if feeling better. Missed doses should be taken as soon as remembered. Advise patient that sharing of this medication may be dangerous.
Advise patient to report signs of superinfection (black, furry overgrowth on the tongue; vaginal itching or discharge; loose or foul-smelling stools) and allergy.
Instruct patient to notify health care professional if fever and diarrhea develop, especially if stool contains blood, pus, or mucus. Advise patient not to treat diarrhea without consulting health care professional.
Instruct patient to notify health care professional if symptoms do not improve.

Evaluation/Desired Outcomes ⬆ ⬇

Resolution of the signs and symptoms of infection. Length of time for complete resolution depends on the organism and site of infection.

Code ⬆

NDC Code

0093- Teva Pharmaceuticals USA, Inc.
- 0093-3123- Dicloxacillin Sodium
  - 0093-3123-01- 100 CAPSULE in 1 BOTTLE (0093-3123-01)

0093- Teva Pharmaceuticals USA, Inc.
- 0093-3125- Dicloxacillin Sodium
  - 0093-3125-01- 100 CAPSULE in 1 BOTTLE (0093-3125-01)

0781- Sandoz Inc
- 0781-2248- Dicloxacillin Sodium
  - 0781-2248-01- 100 CAPSULE in 1 BOTTLE (0781-2248-01)

0781- Sandoz Inc
- 0781-2258- Dicloxacillin Sodium
  - 0781-2258-01- 100 CAPSULE in 1 BOTTLE (0781-2258-01)

33261- Aidarex Pharmaceuticals LLC
- 33261-167- Dicloxacillin Sodium
  - 33261-167-40- 40 CAPSULE in 1 BOTTLE (33261-167-40)

42291- AvKARE, Inc.
- 42291-216- Dicloxacillin Sodium
  - 42291-216-01- 100 CAPSULE in 1 BOTTLE (42291-216-01)

43063- PD-Rx Pharmaceuticals, Inc.
- 43063-180- Dicloxacillin Sodium
  - 43063-180-06- 6 CAPSULE in 1 BOTTLE (43063-180-06)

43063- PD-Rx Pharmaceuticals, Inc.
- 43063-473- Dicloxacillin Sodium
  - 43063-473-20- 20 CAPSULE in 1 BOTTLE, PLASTIC (43063-473-20)

43063- PD-Rx Pharmaceuticals, Inc.
- 43063-473- Dicloxacillin Sodium
  - 43063-473-30- 30 CAPSULE in 1 BOTTLE, PLASTIC (43063-473-30)

50090- A-S Medication Solutions
- 50090-0116- Dicloxacillin Sodium
  - 50090-0116-1- 40 CAPSULE in 1 BOTTLE (50090-0116-1)

50090- A-S Medication Solutions
- 50090-0310- Dicloxacillin Sodium
  - 50090-0310-0- 28 CAPSULE in 1 BOTTLE (50090-0310-0)

50090- A-S Medication Solutions
- 50090-0310- Dicloxacillin Sodium
  - 50090-0310-4- 20 CAPSULE in 1 BOTTLE (50090-0310-4)

50090- A-S Medication Solutions
- 50090-1702- Dicloxacillin Sodium
  - 50090-1702-1- 40 CAPSULE in 1 BOTTLE (50090-1702-1)

50090- A-S Medication Solutions
- 50090-1702- Dicloxacillin Sodium
  - 50090-1702-4- 20 CAPSULE in 1 BOTTLE (50090-1702-4)

50090- A-S Medication Solutions
- 50090-2276- Dicloxacillin Sodium
  - 50090-2276-0- 28 CAPSULE in 1 BOTTLE (50090-2276-0)

55289- PD-Rx Pharmaceuticals, Inc.
- 55289-592- Dicloxacillin Sodium
  - 55289-592-10- 10 CAPSULE in 1 BOTTLE, PLASTIC (55289-592-10)

55289- PD-Rx Pharmaceuticals, Inc.
- 55289-592- Dicloxacillin Sodium
  - 55289-592-20- 20 CAPSULE in 1 BOTTLE, PLASTIC (55289-592-20)

55289- PD-Rx Pharmaceuticals, Inc.
- 55289-592- Dicloxacillin Sodium
  - 55289-592-28- 28 CAPSULE in 1 BOTTLE, PLASTIC (55289-592-28)

55289- PD-Rx Pharmaceuticals, Inc.
- 55289-592- Dicloxacillin Sodium
  - 55289-592-40- 40 CAPSULE in 1 BOTTLE, PLASTIC (55289-592-40)

63629- Bryant Ranch Prepack
- 63629-1350- Dicloxacillin Sodium
  - 63629-1350-1- 20 CAPSULE in 1 BOTTLE (63629-1350-1)

63629- Bryant Ranch Prepack
- 63629-1350- Dicloxacillin Sodium
  - 63629-1350-2- 40 CAPSULE in 1 BOTTLE (63629-1350-2)

63629- Bryant Ranch Prepack
- 63629-1350- Dicloxacillin Sodium
  - 63629-1350-3- 30 CAPSULE in 1 BOTTLE (63629-1350-3)

66267- NuCare Pharmaceticals, Inc.
- 66267-073- Dicloxacillin Sodium
  - 66267-073-28- 28 CAPSULE in 1 BOTTLE (66267-073-28)

66267- NuCare Pharmaceticals, Inc.
- 66267-073- Dicloxacillin Sodium
  - 66267-073-30- 30 CAPSULE in 1 BOTTLE (66267-073-30)

section name header

Pronunciation ⬇

Classifications ⬆ ⬇

Indications ⬆ ⬇

Action ⬆ ⬇

Pharmacokinetics ⬆ ⬇